ICD-10 Coding for Leiomyosarcoma(C49.4, C54.1, C54.1U)
Comprehensive guide on ICD-10 coding for leiomyosarcoma, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Leiomyosarcoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C49.- | Malignant neoplasm of connective and soft tissue | Use when leiomyosarcoma originates in connective or soft tissue. |
|
| C55.9 | Malignant neoplasm of uterus, unspecified | Use for leiomyosarcoma originating in the uterus. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLeiomyosarcoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Leiomyosarcoma.
Omitting morphology code 8890/3.
Impact
Clinical: Misclassification of cancer type., Regulatory: Non-compliance with ICD-10 coding standards., Financial: Potential underpayment due to incorrect DRG.
Mitigation
Review pathology reports for histological confirmation., Ensure morphology code is appended to primary site code.
Coding uterine LMS as benign leiomyoma (D25.9).
Impact
Reimbursement: Incorrect DRG assignment leading to underpayment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data affecting cancer registries.
Mitigation
Require pathology stating 'malignant smooth muscle tumor'.
Morphology code omission
Impact
Failure to include morphology code 8890/3 with primary site code.
Mitigation
Implement coding audits to ensure morphology codes are used.